Detalhe da pesquisa
1.
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Ann Rheum Dis
; 75(1): 45-51, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25660991
2.
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
Rheumatology (Oxford)
; 54(10): 1858-66, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26001633
3.
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
Patient Prefer Adherence
; 8: 1061-71, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25125973
4.
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.
Arthritis Res Ther
; 12(1): R5, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064207
5.
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis.
Open Rheumatol J
; 4: 15-22, 2010 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20461222
6.
Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register.
Arthritis Res Ther
; 8(3): R66, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600016